Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by Barethoughtson Oct 24, 2018 10:07am

179 Views

Post# 28863096

New 52 wk low soon

Great news releases but..Stock promotion warnings on OTC, Paid stock news - example (Oct 11 news release, In order to be in full compliance with the Securities Act of 1933, Section 17(b), we are disclosing that we were paid one thousand dollars from a third party via bank wire to produce content related to New Age Farm.), SP manipulation etc

Sell Sell Sell to me lol

Bullboard Posts

POET increases production capacity to meet AI demand